Visiongain Publishes Medical Imaging Market Report 2020-2030

22 July 2020
Pharma

Visiongain has launched a new report Medical Imaging Market Report 2020-2030: Forecast by Imaging Technology (X-ray, Tomography (Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Single-Photon Emission Tomography), Ultrasound Imaging (2D Ultrasound Systems, 3D and 4D Ultrasound Systems, Doppler Imaging), Radiographic Imaging, Other Imaging Technologies)), by Type (2D Imaging, 3D/4D Imaging), by Software Type (Standalone Software, Integrated Software), by Application (Cardiology, Dental, Mammography, Neurology, Oncology, Orthopaedic, Obstetrics & Gynaecology, Urology and Nephrology), by End Users (Ambulatory Surgical Centers, Clinics, Diagnostic Centers, Hospitals, and Research & Academic Institutions) and by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.

Medical imaging are non-invasive techniques that allow doctors to diagnose diseases and injuries without being intrusive. It has become an essential module of the entire health-care continuum, from screening, early diagnosis, and follow-up. Medical imaging procedures are also used by doctors to determine the best treatment options for patients. Medical imaging tests helps doctors to obtain a better view of organs, blood vessels, tissues, bones, locate tumours, blood clots and other blockages. It also guide medical procedures involving placement of catheters, stents, or other devices inside the body.

According to the Medicare Payment Advisory Commission (MedPAC) and the Centers for Medicare and Medicaid Services (CMS), the rise in volume of imaging services per Medicare beneficiary exceeded the growth of all other services physicians provide. The success of medical imaging is not only about technological advances but also the digital revolution which helped to replace films, permitting multi-planar image reconstruction. Advancements in image acquisition, analysis, transfer, and storage have put medical imaging at the forefront of medical diagnosis. Thus, advances in medical imaging will transform medicine for the masses into precision medicine with personalized care.

The Visiongain report analyst commented “Factors such as increasing demand for early-stage diagnosis of chronic disease and rising aging demographics are anticipated to boost the growth of medical imaging market. In addition, increasing investments, funds, and grants by public-private organizations further drives the market growth.”

On the other hand, shortage of helium, high cost of imaging modalities and unfavourable reimbursement scenario in emerging countries may limit market growth.

The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include GE Healthcare, Philips Healthcare, Hitachi Medical Corporation, Hologic, Inc., Siemens Healthcare, Samsung Medison, Shimadzu Corporation, Toshiba Medical Systems Corporation, Esaote S.P.A, and Fujifilm Corporation.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

Read

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

Read

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

Read

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever